John Frater

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 115 publications

Time to HIV rebound after antiretroviral therapy interruption: a double-blind randomised placebo-controlled trial of long-acting broadly neutralising antibodies; The RIO Trial.

Time to HIV rebound after antiretroviral therapy interruption: a double-blind randomised placebo-controlled trial of long-acting broadly neutralising antibodies; The RIO Trial.

Journal: medRxiv : the preprint server for health sciences

Published: February 12, 2026

T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapy.

T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapy.

Journal: medRxiv : the preprint server for health sciences

Published: February 12, 2026

Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial.

Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial.

Journal: The lancet. HIV

Published: December 09, 2025

Geophagy in Gibraltar Barbary macaques is a primate tradition anthropogenically induced.

Geophagy in Gibraltar Barbary macaques is a primate tradition anthropogenically induced.

Journal: Scientific reports

Published: November 29, 2025

Enhanced HIV-1 Control After Antibody Therapy is Associated with Autologous Antibodies and Reservoir Clearance in the RIO trial.

Enhanced HIV-1 Control After Antibody Therapy is Associated with Autologous Antibodies and Reservoir Clearance in the RIO trial.

Journal: medRxiv : the preprint server for health sciences

Published: November 24, 2025

Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies.

Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies.

Journal: Nature communications

Published: October 29, 2024

Enhancing broadly neutralising antibody suppression of HIV by immune modulation and vaccination.

Enhancing broadly neutralising antibody suppression of HIV by immune modulation and vaccination.

Journal: Frontiers in immunology

Published: August 10, 2024

Footprints of innate immune activity during HIV-1 reservoir cell evolution in early-treated infection.

Footprints of innate immune activity during HIV-1 reservoir cell evolution in early-treated infection.

Journal: The Journal of experimental medicine

Published: June 26, 2024

Impact of antiretroviral therapy during primary HIV infection on T-cell immunity after treatment interruption.

Impact of antiretroviral therapy during primary HIV infection on T-cell immunity after treatment interruption.

Journal: European journal of immunology

Published: April 16, 2024

MHC-related protein 1-restricted recognition of cancer via a semi-invariant TCR-α chain.

MHC-related protein 1-restricted recognition of cancer via a semi-invariant TCR-α chain.

Journal: The Journal of clinical investigation

Published: April 11, 2024

Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trial.

Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trial.

Journal: Journal of virus eradication

Published: March 26, 2024

Rapid antiretroviral therapy in primary HIV-1 infection enhances immune recovery.

Rapid antiretroviral therapy in primary HIV-1 infection enhances immune recovery.

Journal: AIDS (London, England)

Published: December 22, 2023

Showing 1-12 of 115

Last Updated: 09/26/2026